Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.88 USD | +2.26% | +0.57% | -38.37% |
Sales 2024 * | 137M 188M | Sales 2025 * | 215M 294M | Capitalization | 4.66B 6.36B |
---|---|---|---|---|---|
Net income 2024 * | -613M -838M | Net income 2025 * | -584M -798M | EV / Sales 2024 * | 44.2 x |
Net Debt 2024 * | 1.42B 1.94B | Net Debt 2025 * | 1.25B 1.7B | EV / Sales 2025 * | 27.4 x |
P/E ratio 2024 * |
-7.72
x | P/E ratio 2025 * |
-7.95
x | Employees | 553 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.07% |
Latest transcript on BridgeBio Pharma, Inc.
1 day | +2.26% | ||
1 week | +0.57% | ||
Current month | -19.53% | ||
1 month | -16.40% | ||
3 months | -30.77% | ||
6 months | -0.76% | ||
Current year | -38.37% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 14-12-31 |
Charles Homcy
FOU | Founder | 75 | 14-12-31 |
Founder | 73 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 16-02-29 |
Founder | 73 | 14-12-31 | |
Fred Hassan
BRD | Director/Board Member | 78 | 21-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 24.88 | +2.26% | 1,049,219 |
24-04-25 | 24.33 | -2.80% | 1,759,684 |
24-04-24 | 25.03 | -1.69% | 1,540,280 |
24-04-23 | 25.46 | +1.56% | 1,223,615 |
24-04-22 | 25.07 | +1.33% | 2,123,116 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.37% | 4.66B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- BBIO Stock